Brigham and Women's Hospital at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Brigham and Women's Hospital brings 3 presentations to ASH 2026 in New Orleans. Its program spans bleeding and platelet disorders, from the role of glycans in clotting to immune thrombocytopenia that resists steroids and thrombopoietin agonists. It also reports early results of the PEN-Plus model of sickle cell care in resource-poor areas.
| Organization | ASH 2026 Attendance |
|---|---|
Brigham and Women's Hospital Boston, MA | |
Harvard-affiliated academic medical center in Boston, part of Mass General Brigham. | Talk Novel Insights Into the Glycobiology of Hemostasis and Thrombosis How sugar chains on platelet surface proteins form the targets of antiplatelet antibodies, and what that means for clotting and bleeding disorders. Talk Introduction to the PEN-Plus SCD Model of Care and Outcomes From the First Years of Implementation Outcomes for 3,000 rural sickle cell patients in seven countries under a decentralized care model, and lessons from training non-specialist health workers. |
Instantly find 20 buyers from Brigham and Women's Hospital
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction